22 vials of compounded tirzepatide recalled in the US over lack of sterility assurance
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one vial of NAD+ injection because their sterility cannot be assured.
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one vial of NAD+ injection because their sterility cannot be assured.
In October 2026 the EMA's human medicines committee recommended making Nyxoid (naloxone) available without a prescription.
On 16 October 2026 the EMA's human medicines committee recommended authorising Foundayo (orforglipron) in the EU.
The UK medicines regulator and West Midlands Police seized more than 12,000 fake weight-loss pens in a raid on 14 October 2026.
On 9 October 2026 the FDA approved Hovilpri (pritelivir) tablets for herpes simplex lesions in immunocompromised adults.
Ignaz Semmelweis (1818–1865) was a Hungarian obstetrician later called the saviour of mothers.
Switzerland has reported 4 locally acquired chikungunya cases in the canton of Ticino, the first in the country.
Saudi Arabia reported eight laboratory-confirmed MERS-CoV cases, including one death, between 1 January and 5 October 2026.
On 2 October 2026 the FDA approved Jaypirca (pirtobrutinib) for adults with previously untreated chronic lymphocytic leukemia.
A University of Oulu registry study followed 652 women with breast cancer that had spread to the bones.
Nothing more to show